SCMP Group Launches EsquireHK.com

First and Only International Men’s Fashion & Lifestyle Media Brand to Kick-start Multimedia Website in HK

HONG KONG, Aug. 26, 2014 /PRNewswire/ — SCMP Group Ltd (SEHK: 583), Asia’s leading media holding company, today announced that it will launch EsquireHK.com on 1 September, establishing Esquire as the first and only international men’s fashion & lifestyle media brand with a localized multimedia online presence in Hong Kong. This follows the publication of Esquire’s Chinese version in January after SCMP Hearst Magazines Limited, a joint venture between SCMP Group and Hearst Magazines International, acquired its publication rights in Hong Kong.

Leveraging the resonance of the print edition’s lifestyle and fashion content, EsquireHK.com will enrich readers’ experience with a host of multimedia daily-refreshed channels on Style, Lifestyle, Watches, Food & Drinks, Machines, People and Esquire TV. The new website shares the signature brand essence and motif of its US counterpart esquire.com, while infusing Hong Kong and international editorial directions with local flair.  EsquireHK.com is powered by multi-talented online editorial specialists that create daily lifestyle & fashion news, reviews, tips, how-to guides and interviews using lively language, videos, photos, infographics and images.

SCMP Group announced that EsquireHK.com will be launched on 1 Sep, establishing Esquire as the first and only international men’s fashion & lifestyle media brand with a localized multimedia online presence in Hong Kong.

SCMP Group announced that EsquireHK.com will be launched on 1 Sep, establishing Esquire as the first and only international men’s fashion & lifestyle media brand with a localized multimedia online presence in Hong Kong.

Ms. Josephine Chan, Managing Director, SCMP Magazines Publishing Ltd said, “Through research and focus groups, we confirmed our belief that there is a dearth of men’s fashion and lifestyle websites with quality and original content in sync with what Hong Kong readers are looking for. EsquireHK.com helps us bridge this important market void, while strengthening our connection with readers, and importantly, building on the success that Esquire print has attained since the January launch.”

Ms. Chan added, “With daily updated content, EsquireHK.com will become indispensable to marketers and advertisers looking for an integrated men-focused advertising and promotion platform. In Esquire magazine and Esquirehk.com, they will be able to direct their promotional efforts to a high-value group of target audience that cares about style and substance.”

An online campaign titled “Are you THE MAN?” has preempted the website launch and introduced readers to Esquire HK’s brand essence – modern, sophisticated, confident and detailed.  Created by the EsquireHK.com team, the campaign is making a splash with visitors, some of whom heard about it from Esquire’s HK Facebook page. The campaign challenges site visitors to test their understanding of “Lifestyle, Style, Workplace and Party”. Registered participants who submit outstanding answers will win special prizes. The campaign www.esquireHK.com/areyoutheman will end on September 7.

About SCMP Group Ltd and South China Morning Post

SCMP Group Limited (SEHK: 583) is a leading newspaper and magazine publisher in Asia. Its flagship publication, South China Morning Post, is Hong Kong’s internationally recognised English language newspaper and has the city’s most affluent and influential readership.

First published in 1903, the newspaper has developed an enviable reputation for authoritative, influential and independent reporting on Hong Kong, Mainland China and the rest of Asia. Available in print, mobile, tablets and online through scmp.com and e-reader editions, South China Morning Post reaches a global audience with daily breaking news, analysis and opinion, multimedia articles and interactive forums. The South China Morning Post received over 160 awards in 2013-14 for excellence in editorial, marketing and technical capability.  Other titles in the Group include the Sunday Morning Post, Nanzao.com, Nanzaozhinan.com, STYLE, Destination Macau, The PEAK, HK Magazine, The List, Where Hong Kong, and Where Chinese.

Through the joint venture partnership with Hearst, SCMP Hearst publishes the Chinese editions of Cosmopolitan, CosmoBride, Harper’s BAZAAR, Harper’s BAZAAR Art, Harper’s BAZAAR Bride, Esquire, ELLE, ELLE Men, ELLE Wedding, ELLE Decoration, and ELLE Accessories; and operates Cosmopolitan.com.hk, Cosmogirl.com.hk, Harpersbazaar.com.hk, ELLE.com and EsquireHK.com in Hong Kong.

For further information please contact:              

+852-2680-8888
communications@scmp.com

Photo – http://photos.prnasia.com/prnh/20140826/8521404785

For Singaporeans, 50 is the new 45

Nine in 10 Singaporeans aged over 50 believe that a positive attitude is key to feeling younger, while laughing is the best anti-ageing medicine

SINGAPORE, Aug. 27, 2014 /PRNewswire/ — A new study reveals that 70 per cent of Singaporeans over the age of 50 feel five years younger than their actual age.

GSK launches a fun, consumer version of the Inner Age Index for Singaporeans to find out their inner age. Find out your inner age at www.actyourinnerage.com.sg

GSK launches a fun, consumer version of the Inner Age Index for Singaporeans to find out their inner age. Find out your inner age at www.actyourinnerage.com.sg

The Inner Age Index[1], commissioned by leading healthcare company GSK, provides new insight on Singaporean attitudes towards growing older as the nation faces a shrinking and ageing population. The study explores the concept of “inner age” — how old someone perceive themselves to be as compared to how old they actually are — and how ageing is perceived through a Singaporean lens.

The results of the study show that ageing is more about attitude than the physical passing of time. The results reveal that nine in 10 Singaporeans aged over 50 believe that a positive attitude is the key to feeling younger, while laughing is the best anti-ageing medicine. Those with a younger inner age were also more likely to report they’re living life to the full (85 per cent), and feel more fulfilled now than ever before (72 per cent).

In addition, many Singaporeans over the age of 50 years report feeling good about their appearance with 81 per cent stating that they like to look their best and 74 per cent feeling proud to reveal their real age.

Mr Gijs Sanders, General Manager of GSK’s Consumer Healthcare business in Singapore, says that these findings challenge traditional perceptions of ageing.

“People over the age of 50 now make up almost a quarter of the population in Singapore. While there is currently much discussion around the health and societal implications of an ageing population, our study shows that the vast majority of Singaporeans over the age of 50 feel youthful, vibrant and are not defined by age.”

“GSK conducted the Inner Age Index because we believe the current national conversation about ageing can be really positive as people take the opportunity to pursue long-held passions and lead a fulfilled lifestyle. By encouraging this conversation we hope to encourage Singaporeans over the age of 50 to do more, feel better and live longer.”

The Inner Age Index found that the majority (75 per cent) of older Singaporeans like to stay socially active and many (64 per cent) believe that being over 50 means they have finally found the time to realise passions, such as socialising with friends, travelling, playing sports and exercising. When asked if they could go back in time, nearly two in five survey participants said they wouldn’t change a thing.

There was also a strong relationship between Singaporeans with a younger inner age and a positive perception of health, and more than half (57 per cent) of respondents stated they are proactive when it comes to taking care of their own health.

Find out your inner age using The Inner Age Test — an adapted consumer version of the Inner Age Index. To take the test, visit actyourinnerage.com.sg

[1] The Inner Age Index. A face-to-face survey of 150 Singaporeans conducted by Edelman Berland, commissioned by GSK. July 2014.

For more information or to request an interview, please contact:

Jolene Ng

Edelman

Jolene.Ng@edelman.com

Tel: +65-6347-2314

Melissa-Anne Bheem

Edelman

Melissa-Anne.Bheem@edelman.com  

Tel: +65-6347-2341

About the Inner Age Index

The Inner Age Index, commissioned by GSK and conducted by global market research and strategic consulting firm Edelman Berland, is a survey of Singaporeans aged over 50 on their perceptions, attitudes and behaviours towards ageing. The survey was conducted with 150 Singaporean citizens aged 50 and above from across the island.

 The inner age of a person, in contrast to the real or chronological age of a person, is a subjective representation of how old a person acts or feels. This means that “inner age” is not a scientifically defined term. It is not representative or indicative of the participant’s physical ability or well being or be relied upon as a representation of such.

GSK has developed the Inner Age Index to create awareness and facilitate a dialogue concerning the challenges and solutions for an increasingly ageing population.

About GSK

GSK, one of the world’s leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.

About RSVP Singapore

RSVP’s mission is to provide opportunities for people over 50 to serve the community with their talent and experience through purpose-driven volunteerism.  Whether it’s playing a musical instrument, taking up photography or learning the latest in ICT, RSVP volunteers pursue their passions by sharing and giving back to the community. They not only lead active and fulfilled lives but also give joy to others in society who are less fortunate than themselves. They believe that volunteerism while pursuing your interests and abilities can come together for a positive ageing experience.

Photo – http://photos.prnasia.com/prnh/20140826/8521404788

Leading Architectural Design Firm NBBJ Launches Healthcare Practice in China

SHANGHAI, Aug. 27, 2014 /PRNewswire/ — Global design and architecture firm NBBJ announced today the expansion of its healthcare planning and design services into China. Principal Rudy Widjaja will lead planning and design teams from NBBJ’s Shanghai office, where he will draw on his experience with healthcare clients in mainland China, Taiwan, Korea and the United States, as well as the firm’s global network of healthcare experts.  

The launch of NBBJ’s China healthcare practice comes at a time when the scope of the firm’s healthcare practice in Asia is increasing, with work for Shanghai Children’s Medical Center in mainland China; the Koo Foundation Sun Yat-Sen Cancer Center in Taipei, Taiwan; and the Samsung Medical Center in Seoul, Korea, among other projects.

Joan Saba, AIA, FACHA, Partner at NBBJ and the leader of its global healthcare practice, said: “We’ve successfully extended our innovative healthcare facilities concepts across the U.S., Europe and the Middle East. While we have long been serving select healthcare clients in China, we are very excited to deepen our practice by building a strong China team for future clients.”

“By formalizing our healthcare practice, we are now able to bring NBBJ’s renowned healthcare design expertise to our Chinese clients more readily. We can adapt best and future practices to the specific technical and cultural needs in China as new private healthcare models emerge,” added Principal Rudy Widjaja.  

For seventy years, NBBJ’s vision and compassion have helped shape many of the world’s most progressive academic medical centers, teaching hospitals, specialty hospitals, community hospitals, ambulatory care centers, medical office buildings and specialty facilities. NBBJ has worked with 11 of the top 17 U.S. News & World Report Honor Roll Hospitals. Clients include American University of Beirut Medical Center, Brigham and Women’s Hospital (a teaching affiliate of Harvard Medical School), Cambridge University, the Children’s Hospital of Philadelphia, Cleveland Clinic, Kaiser Permanente, the Kuwait Ministry of Health, Mayo Clinic, Massachusetts General Hospital, NYU Langone Medical Center, the Royal Liverpool University Hospital, the University of Pennsylvania Health System and Virginia Mason.

The firm successfully blends healing environments with efficient, evidence-based design and research. This approach has earned NBBJ notable accolades, including being named “Firm of the Year” and “Healthcare Architect of the Year” (for Joan Saba) by Healthcare Design and “Most Admired Healthcare Firm” by Interior Design for seven consecutive years. NBBJ is ranked as the second-largest healthcare architect in the world, according to BD World Architecture, and by Engineering News-Record as the “#1 Green Architecture Firm.” The firm has been the recipient of more than 300 healthcare design awards.

In the late 1990s, NBBJ formed a team to meet clients’ demand for services in a rapidly growing Asia market, which led to the opening of the Shanghai office in 2005. In China, NBBJ is currently designing corporate offices for Alipay in Hangzhou, Suning in Nanjing, Tencent in Shenzhen and WeChat in Guangzhou. Commercial mixed-use developments include Yanlord Landmark in Chengdu and Eton Place in Xiamen. Recent sports and convention centers include the Hangzhou Olympic Sports Center in Hangzhou, the Asia World Expo in Hong Kong and the Qingdao Aoshan Bay International Exhibition Center. The firm’s master planning work spans the country, from the waterfront redevelopment of the Shanghai Bund to the 25,000-hectare city master plan for Karamay. NBBJ is the recipient of multiple MIPIM Asia, Cityscape and ASLA awards for its work in China.

To celebrate the expansion of the Chinese healthcare practice, NBBJ Partners Joan Saba and Timothy Johnson as well as Principal Rudy Widjaja are hosting a salon event, “Healthy China: What’s Next for Healthcare and Cities,” which will take place at The Langham, Xintiandi Shanghai, September 15, 2014, from 6:00 to 9:00 pm.

The invitation-only salon is a platform for discussion and knowledge sharing among leaders, thinkers and builders of health practice and health facilities. The format for the evening will be a panel discussion moderated by the Editor-in-Chief of Forbes (China) magazine, Jiangong Zhou. Panelists include John Cai, Director, Centre for Healthcare Management and Policy, and Adjunct Professor of Economics, China Europe International Business School (CEIBS); Hongyang Wang, Professor, School of Architecture and Urban Planning, Nanjing University; Joseph D. Tucker, Director, UNC Project-China; and Joan Saba, Healthcare Design Partner, NBBJ.

For more information:
US: Helen Dimoff, Director of Communications, NBBJ, hdimoff@nbbj.com
China: Stella Ye, stella.ye@motto-consulting.com.cn

For more information on the event:
http://www.nbbj.com/news/2014/8/11/healthy-china-whats-next-for-healthcare-and-cities/

To request an invitation to the event:
Cindy Wu, cwu@nbbj.com

About NBBJ
NBBJ creates innovative places and experiences for organizations worldwide, and designs environments, communities and buildings that enhance people’s lives. Founded in 1943, NBBJ is an industry leader in healthcare and corporate facilities and has a strong presence in the commercial, civic, science, education and sports markets. The firm has won numerous awards and has been recognized as one of the world’s “Top Ten Most Innovative Architecture Firms” by Fast Company magazine. NBBJ has more than 750 employees in ten offices worldwide, including Beijing, Boston, Columbus, London, Los Angeles, New York, Pune, San Francisco, Seattle and Shanghai. Clients include Alibaba, Amazon, the Bill & Melinda Gates Foundation, Boeing, Cambridge University, Cleveland Clinic, GlaxoSmithKline, Google, Massachusetts General Hospital, Microsoft, Reebok, Salk Institute, Samsung, Stanford University, Starbucks, Telenor, Tencent and the Wellcome Trust.

http://www.nbbj.com

Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe

– Vendors focus on multi-modality equipment that improves the efficiency, specificity and sensitivity of breast cancer screening

LONDON, Aug. 26, 2014 /PRNewswire/ — National population-based screening programs for asymptomatic women aged 40 and above have been established in many European countries for early detection of breast cancer. With every passing year, this population cohort is expanding, spurring breast cancer screening rates and fuelling the need for breast imaging systems. With the number of women being diagnosed with breast cancer also bound to increase, the adoption of equipment for procedures such as biopsy and image guidance too will grow.

Logo – http://photos.prnewswire.com/prnh/20140826/139581

New analysis from Frost & Sullivan, Analysis of the European Breast Imaging Systems Market, finds that the market earned revenues of $988.3 million in 2013 and estimates this to reach $1,384.2 million in 2020. The study covers x-ray mammography, breast ultrasound, breast magnetic resonance imaging (MRI), molecular breast imaging (MBI), and breast computer-aided detection (CAD).

While mammography has been considered the ‘gold standard’ for breast screening, adjunct technologies such as breast ultrasound, breast MRI and MBI too are gaining traction as they improve the standards of diagnosis and treatment of breast cancers.

“The European market will continue to evolve as breast imaging systems vendors look for innovative technologies to battle the increasing rate of false positives and overcome limitations while scanning women with dense breast tissue,” said Frost & Sullivan Healthcare Research Analyst Raghuraman Madanagopal. “3-D tomosynthesis, automated breast ultrasound and MBI are the results of such technological innovations that ensure maximum efficiency and minimum error rates.”

However, sporadic reimbursement trends across countries may lead to equally sporadic uptake of these advanced modalities for breast imaging. While the more commonly performed mammography and the less expensive ultrasound procedures are reimbursed sufficiently, the trend changes for costly procedures such as MRI and MBI.

To overcome this restraint, many breast imaging facilities in Europe are employing multi-modality screening. This, in turn, is expected to drive the use of supplementary modalities such as breast ultrasound.

“Research studies in recent years have validated the benefits that multi-modality screening provides over regular mammography screening, since one modality can overcome the limitations of another,” noted Madanagopal. “In accordance with this validation that a multi-modality approach improves the efficiency, specificity and sensitivity of breast cancer screening procedures, a wide product portfolio will be a core competitive factor in the European breast imaging systems market.”

If you are interested in more information on this study, please email Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Analysis of the European Breast Imaging Systems Market is part of the Advanced Medical Technologies Growth Partnership Service program. Frost & Sullivan’s related studies include: US Nuclear Medicine and PET Imaging Systems Market, and European Ultrasound Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: anna.zanchi@frost.com

http://www.frost.com

Logo – http://photos.prnasia.com/prnh/20140826/8521404802LOGO

Cole Haan Unveils Exclusive ZeroGrand shoes with award-winning global retailer MR PORTER.COM

NEW YORK, Aug. 26, 2014 /PRNewswire/ — Cole Haan, the iconic American lifestyle footwear and accessories brand and retailer, today announces an exclusive release with MR PORTER.COM, the award-winning global retail destination for men’s style. The assortment of six styles consists of the ZeroGrand Wing Ox and two silhouettes designed exclusively for the retailer, the new ZeroGrand Chukka and ZeroGrand Tassel Loafer.

“MR PORTER is the most innovative online men’s shop in the world. It only made sense to bring our most innovative product to them. Upon seeing ZeroGrand, we immediately set to work with them to tailor ZeroGrand to the discerning MR PORTER customer,” remarked David Maddocks, Chief Marketing Officer at Cole Haan.

Cole Haan partnered with MR PORTER to determine all details in this new iteration of dress and casual footwear. The result is a masculine palette that easily coordinates with every man’s wardrobe. The styles all feature an Ivory outsole, which is a main characteristic within the collection.

Expanding on ZeroGrand’s collision of innovation and craft, the unlined shoes use reverse full-grain uppers, a luxurious suede from the long-standing British tannery Charles F. Stead. Each lightweight pair in the collection makes for a perfect Pre-Fall choice, that easily transitions into cooler seasons. Originally launched in July 2014, ZeroGrand features Cole Haan’s new “operating system,” Grand.OS, which delivers greater flexibility, reduced weight and increased cushioning in products that move easily from work to weekend with ease.

“Cole Haan is an exciting new addition to MR PORTER, and we’ve worked with them to produce some exclusive styles on the new ZeroGrand sole unit. Our customer is always looking for something new, and this will be our first offering of a classic shoe x sneaker hybrid,” says Sam Lobban, Senior Buyer at MR PORTER.

Available from mrporter.com starting August 26, the ZeroGrand Chukka ($278) will come in Ivy and Mushroom, the ZeroGrand Tassel Loafer ($268) will come in Mushroom and India Ink ($268), and the ZeroGrand Wing Ox ($268) will come in Ironstone and Black.

For more information, contact:

Kimry Blackwelder, Cole Haan

Nick Troedson, MR PORTER

+1 (212) 763-3060

+1 (852) 3018-6076

kimry.blackwelder@colehaan.com

nick.troedson@mrporter.com

About Cole Haan:

Cole Haan LLC, with its Global Creative Center in New York City, is an iconic American lifestyle accessories brand and retailer of premium men’s and women’s footwear and bags, outerwear, eyewear and accessories with a commitment to craftsmanship, timeless style and design innovation. For more information, visit ColeHaan.com and follow @ColeHaan.

About MR PORTER:

MR PORTER is the award-winning global retail destination for men’s style, combining the best international menswear with editorial content.  The site sells over 200 leading international brands, with content and new products added weekly.  MR PORTER offers express worldwide shipping to 170 countries (including same day delivery to London and New York), and a free collection service for returns and exchanges.  For more information, visit mrporter.com.

Photo – http://photos.prnewswire.com/prnh/20140820/138291
Photo – http://photos.prnewswire.com/prnh/20140820/138296

Frost & Sullivan Applauds Volpara Solutions’ Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer

Volpara Solutions is the only company with a dose measurement tool specifically for breast imaging

MOUNTAIN VIEW, Calif., Aug. 26, 2014 /PRNewswire/ — Based on its recent analysis of the breast imaging solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership. Volpara Solutions offers an innovative range of volumetric breast imaging solutions for the early detection of breast cancer. Over the past few years, the company has steadily introduced several new solutions and has expanded its global reach to cover the United States, Europe, Asia and Australia.

Volpara’s suite of quantitative solutions includes VolparaDose, VolparaDensity, VolparaAnalytics and VolparaResearch. The Density and Dose solutions are patient-specific, while the Analytics and Research solutions are clinic-wide monitoring tools.

VolparaDensity automatically generates an objective measurement of volumetric breast density and a FDA-cleared BI-RADS breast density category, while VolparaDose helps keep track of patient-specific dose exposure. VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help understand the performance of technologists, readers, and mammography and tomosynthesis machines. VolparaResearch is aimed at research facilities that are looking to analyze large datasets of breast measurement information captured across time.

“Frost & Sullivan lauds Volpara Solutions for continuous leadership in technology innovation, thoughtfulness in identifying the unmet need for dose tracking in breast imaging, and a clear vision for what analytics can achieve in the early detection and treatment of breast cancer. Furthermore, all of the applications are built to serve across both full-field digital mammography and digital tomosynthesis systems, and with multi-vendor compatibility and reproducible data,” said Frost & Sullivan Research Director, Advanced Medical Technologies Group, Siddharth Saha. “This is of high relevance in the industry, as tomosynthesis is quickly gaining currency, with 30 percent of the members of the Society of Breast Imaging in the U.S. already using it.”

VolparaDose, along with VolparaAnalytics, gives radiologists patient-specific quantitative data to help minimize dose in mammography and tomosynthesis while maintaining image quality. While several market participants offer breast density measurement tools, Frost & Sullivan confirms that Volpara Solutions is the only company with a dose measurement tool specifically for breast imaging. It is necessary to measure volumetric breast density to control the dose, and Volpara Solutions has emerged as a pioneer in leveraging the Mega Trend of Dose Reduction by acknowledging patient-specific dose tracking and reporting as a white-space opportunity.

Furthermore, by enabling radiologists to track density and dose scores across time, Volpara Solutions helps support the movement toward the personalization of breast screening. Women with lower density have a lower risk of breast cancer, and researchers are looking at incorporating breast density into risk models that may support personalized screening protocols, which can include the best adjuvant imaging options for that woman (including breast tomosynthesis, automated whole breast ultrasound, molecular breast imaging, and breast MRI) as well as the frequency of screening.

“We are very proud to be recognized for the innovative solutions we have brought to the breast imaging market and for our vision and commitment to address unmet needs in the detection, prevention and treatment of breast cancer,” noted Ralph Highnam, Ph.D., Volpara Solutions’ CEO and chief scientist. “By allowing researchers across the globe to compare data to detect geographical, racial and age-related trends, we hope to take breast cancer research to the next level, which could lead to the development of predictive analytical models that will revolutionize early detection of breast cancer and save lives.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend toward innovation, its relevance to the industry and the positive impact on brand perception.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Volpara Solutions

Founded to enable radiologists to give women the most accurate information possible regarding their breast health, Volpara Solutions is the wholly owned sales and marketing arm of Matakina Technology Limited of New Zealand. Matakina’s founders and Board of Directors include John Hood, Ph.D., former Vice Chancellor of the University of Oxford, UK; Ralph Highnam, Ph.D., former CEO of Mirada Solutions, one of the University of Oxford’s most successful spin-outs of recent times, and co-author of the seminal book Mammographic Image Analysis; and Professor Sir Michael Brady, a serial entrepreneur who recently retired from the University of Oxford, where he was Professor of Information Technology for 25 years.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on “the next big thing”

Register:        Gain access to visionary innovation

Contact:

Frost & Sullivan            

Volpara Solutions

Mireya Espinoza             

Chris Joseph

P: 210. 247.3870            

P: 510.339.2293

F: 210.348.1003             

E: chris.joseph@volparasolutions.com

E: mireya.espinoza@frost.com

 

 

Frost & Sullivan: Quantified-self Technologies Set to Transform Personal Health

— Innovations in sensor technology usher in an era of self-monitoring devices

MOUNTAIN VIEW, Calif., Aug. 26, 2014 /PRNewswire/ — The market for quantified-self technologies — apps that enable people to track and quantify aspects of their daily lives — is currently in the embryonic stage. However, explosive growth is expected in coming years as many companies successfully complete crowd sourcing activities for funding; an indication of the high interest the domain has generated. Communication, computing, data capture and feedback mechanisms will be key technology enablers for quantified-self.

The market for quantified-self technologies – apps that enable people to track and quantify aspects of their daily lives – is currently in the embryonic stage.

The market for quantified-self technologies – apps that enable people to track and quantify aspects of their daily lives – is currently in the embryonic stage.

New analysis from Frost & Sullivan, Sensor Technology Innovations Enabling Quantified-Self, finds that wearable technology has gained considerable traction especially in the health and wellness industry. Increasing momentum in the use of sensor-enabled wearable devices promises more design opportunities in the future.

For complimentary access to more information on this research, please visit: http://bit.ly/1BWbUxW

“The miniaturization trend has quickened development of improved and innovative wearable devices such as smart watches and smart glasses that monitor athletic performance and health,” said Technical Insights Senior Research Analyst Sumit Kumar Pal. “Quantified-self facilitates the tracking of diet, sleep, heart rate, activity, exercise and moods and allows individuals to gain better insights on physiological parameters that were never examined earlier.”

As healthcare is one of the main industries impacted by the quantified-self movement, acquiring accurate data and ensuring seamless interoperability are key challenges. In addition, data sharing among health services and pharmaceutical firms raises privacy concerns. Healthcare companies must ensure that data collected from clients is not shared without direct consent.

User perceived benefits will be another critical factor in the success of quantified-self products, along with affordability. To get the healthcare industry further involved in quantified-self, enhancing the connectivity of wearable devices with technology companies to support data exchange will also be crucial.

“Stakeholders are exploring other ecosystems with which quantified-self can be integrated,” added Pal. “Technological advancements in energy harvesting for mobile and wearable devices as well as in social networking dynamics will push the quantified-self industry into the next stage.”

Sensor Technology Innovations Enabling Quantified-Self, a part of the Technical Insights (http://www.technicalinsights.frost.com) subscription, offers technological and market insights on sensors enabling quantified-self. Along with a snapshot of the technology’s global footprint, the study discusses patent publishing trends, R&D focus, funding, and the impact of mega trends to provide a complete view of quantified-self technology. Detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters, and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion

Join Us: Join our community

Subscribe: Newsletter on “the next big thing”

Register: Gain access to visionary innovation

Sensor Technology Innovations Enabling Quantified-Self
D547-TI

Contact:
Jennifer Carson
Corporate Communications – North America
P: +1-210-247-2450
F: +1-210-348-1003
E: jennifer.carson@frost.com

LinkedIn: Transform Health Group
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com
http://www.technicalinsights.frost.com